(Q45036700)

8 December 2017

title

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). (English)

1 reference

8 December 2017

1 reference

8

John Kjekshus

1 reference

8 December 2017

Timo E Strandberg

1

1 reference

8 December 2017

Kalevi Pyörälä

2

1 reference

8 December 2017

Thomas J Cook

3

1 reference

8 December 2017

Lars Wilhelmsen

4

1 reference

8 December 2017

Ole Faergeman

5

1 reference

8 December 2017

Gudmundur Thorgeirsson

6

1 reference

8 December 2017

Terje R Pedersen

7

1 reference

8 December 2017

4S Group

9

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

364

1 reference

8 December 2017

issue

9436

1 reference

8 December 2017

page(s)

771-777

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Do statins cause cancer? A meta-analysis of large randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Statins and cancer: a case of meta-uncertainty

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Report of the Conference on Low Blood Cholesterol: Mortality Associations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Should there be a moratorium on the use of cholesterol lowering drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

Statin effects beyond lipid lowering--are they clinically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916936-5

7 January 2021

10.1016/S0140-6736(04)16936-5

Identifiers

DOI

1 reference

8 December 2017

1 reference